摘要
慢性阻塞性肺疾病(COPD)是我国常见和重要危害国人身体健康的慢性呼吸道疾病。随着年龄的增长,慢阻肺患病率呈指数型增加,其亦是一种增龄相关性疾病(老年病)。衰弱和肌少症是老年医学科临床上重要的两种老年综合征,往往与慢阻肺患者的临床不良结局密切相关。本文就衰弱和肌少症的临床评估工具,慢阻肺时两种老年综合征的流行病学,生物学机制及可能的干预策略等做一述评。
Chronic obstructive pulmonary disease(COPD),one of themost common and important chronic respiratory disease,is a great threat for public health in China.The prevalence of COPD increases exponentially in advancing age.COPD is also an age-related disease.Frailty and sarcopenia are clinically important geriatric syndromes in geriatric medicine.The two syndromes are closely related to poor outcomes in patients with COPD.This editorial is on clinical assessment tools of frailty and sarcopenia,epidemiological evidence and biological mechanism of the two syndromes in COPD and potential intervention strategies.
作者
袁益明
王英
YUAN Yiming;WANG Ying(Department of Geriatric Medicine,West China Hospital,Sichuan University,Chengdu 610041,China)
出处
《西部医学》
2018年第12期1717-1720,共4页
Medical Journal of West China
基金
四川省科技厅重点攻关项目(2018SZ0171)
四川省干部保健高层次人才培养基金项目(2018)
关键词
慢性阻塞性肺疾病
老年综合征
衰弱
肌少症
老年医学
Chronic obstructive pulmonary disease
Geriatric syndrome
Frailty
Sarcopenia
Gerontology